Factors associated with fatigue in sarcoidosis

Respiratory Care

Volumn 59, Issue 7, 2014, Pages 1086-1094

  Fleischer, Michael ^a   Hinz, Andreas ^a   Brähler, Elmar ^a   Wirtz, Hubert ^b   Bosse Henck, Andrea ^b  

^a Department of Medical Psychology and Medical Sociology ^*  (United States)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Comorbidity; Fatigue; Organs; Sarcoidosis

Indexed keywords

AZATHIOPRINE; METHOTREXATE; PREDNISOLONE; ANTIINFLAMMATORY AGENT; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; COMORBIDITY; DIABETES MELLITUS; EYE; FATIGUE; FATIGUE ASSESSMENT SCALE; FEMALE; HEALTH IMPACT ASSESSMENT; HUMAN; LUNG; LUNG SARCOIDOSIS; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MULTIDIMENSIONAL FATIGUE INVENTORY; MULTIPLE REGRESSION; OBESITY; PULMONARY HYPERTENSION; QUESTIONNAIRE; REGRESSION ANALYSIS; RESTLESS LEGS SYNDROME; SKIN; SLEEP DISORDERED BREATHING; THYROID DISEASE; COHORT ANALYSIS; COMPLICATION; GERMANY; MIDDLE AGED; PATHOLOGY; RISK FACTOR; SARCOIDOSIS;

ADULT; ANTI-INFLAMMATORY AGENTS; AZATHIOPRINE; COHORT STUDIES; FATIGUE; FEMALE; GERMANY; HUMANS; HYPERTENSION, PULMONARY; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; MIDDLE AGED; PREDNISOLONE; QUESTIONNAIRES; RISK FACTORS; SARCOIDOSIS; SLEEP APNEA SYNDROMES;

EID: 84920115093     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.02080     Document Type: Article

References (41)

1. Judson MA. Sarcoidosis: clinical presentation, diagnosis, and approach to treatment. Am J Med Sci 2008: 335(1): 26-33.
2. Dempsey OJ, Paterson EW, Kerr KM. Denison AR. Sarcoidosis. BMJ 2009; 339: b3206.
3. Nunes H, Bouvry D, Soler P, Valeyre D. Sarcoidosis. Orphanet J Rare Dis 2007; 2: 46.
4. Drew M, Verbraecken J, van der Grinten C, Wouters E. Fatigue associated with obstructive sleep apnea in a patient with sarcoidosis. Respiration 2000; 67(3): 337-340.
5. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007; 357(21): 2153-2165.
6. Sharma OP. Fatigue and sarcoidosis. Eur Respir J 1999; 13(4): 713-714.
7. Drent M, Wirnsberger RM, Breteler MH, Kock LM, de Vries J, Wouters EF. Quality-of-life and depressive symptoms in patients suffering from sarcoidosis. Sarcoidosis Vase Diffuse Lung Dis 1998; 15(1): 59-66.
8. Michielsen HJ, Peros-Golubicic T, Drent M, De Vries J. Relationship between symptoms and quality of life in a sarcoidosis population. Respiration 2007; 74(4): 401-405.
9. Hinz A, Fleischer M, BrählerE, Wirtz H, Bosse-Henck A. Fatigue in patients with sarcoidosis, compared with the general population. Gen Hosp Psychiatry 2011; 33(5): 462-468.
10. de Kleijn WP, Elfferich MD, De Vries J, Jonker GJ, Lower EE, Baughman RP. et al. Fatigue in sarcoidosis: American versus Dutch patients. Sarcoidosis Vase Diífuse Lung Dis 2009; 26(2): 92-97.
11. Gvozdenovic BS, Mihailovic-Vucinic V, Ilic-Dudvarski A. Zugie V, Judson MA. Differences in symptom severity and health status impairment between patients with pulmonary and pulmonary plus ex-trapulmonary sarcoidosis. Respir Med 2008; 102(11): 1636-1642.
12. Grandjean P. [Restless legs syndrome-current aspects]. Praxis (Bern 1994) 1997; 86(18): 732-736. Article in German.
13. Banno K, Delaive K, Walld R, Kryger MH. Restless legs syndrome in 218 patients: associated disorders. Sleep Med 2000; 1(3): 221-229.
14. Reimer MA, Flemons WW. Quality of life in sleep disorders. Sleep Med Rev 2003; 7(4): 335-349.
15. Mills PJ, Kim JH, Bardwell W, Hong S, Dimsdale JE. Predictors of fatigue in obstructive sleep apnea. Sleep Breath 2008; 12(4): 397-399.
16. Maloney EM, Boneva RS, Lin JM, Reeves WC. Chronic fatigue syndrome is associated with metabolic syndrome: results from a case-control study in Georgia. Metabolism 2010: 59(9): 1351-1357.
17. Vgontzas AN. Bixler EO, Chrousos GP. Obesity-related sleepiness and fatigue: the role of the stress system and cytokines. Ann N Y Acad Sci 2006; 1083: 329-344.
18. Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000: 85(3): 1151-1158.
19. Palmero V, Sulica R. Sarcoidosis-associated pulmonary hypertension: assessment and management. Semin Respir Crit Care Med 2010; 31 (4): 494-500.
20. Baughman RP, Sparkman BK, Lower EE. Six-minute walk test and health status assessment in sarcoidosis. Chest 2007; 132(1): 207-213.
21. Curtis JR, Westfall AO, Allison J, Bijlsma JW, Freeman A, George V, et al. Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Rheum 2006: 55(3): 420-426.
22. de Kleijn WP, De Vries J. Lower EE, Elfferich MD. Baughman RP. Drent M. Fatigue in sarcoidosis: a systematic review. Curr Opin Pulm Med 2009; 15(5): 499-506.
23. Schäflein E, Wettach I, Smolka R, Kuprion J. Zipfel S, Teufel M. [Extensive interactions between eating and weight disorder, major depression, pain, and sarcoidosis-case 5/2012], Dtsch Med Wochen-schr 2012; 137(23): 1267. Article in German.
24. Michielsen HJ, De Vries J, Van Heck GL. Psychometric qualities of a brief self-rated fatigue measure: the fatigue assessment scale. J Psy-chosom Res 2003; 54(4): 345-352.
25. De Vries J, Michielsen H, Van Heck GL. Drent M. Measuring fatigue in sarcoidosis: the Fatigue Assessment Scale (FAS). Br J Health Psychol 2004; 9(Pt 3): 279-291.
26. Smets EM, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995; 39(3): 315-325.
27. Thombs BD, Bassel M, McGuire L. Smith MT, Hudson M. Hay-thornthwaite JA. A systematic comparison of fatigue levels in systemic sclerosis with general population, cancer, and rheumatic disease samples. Rheumatology (Oxford) 2008: 47(10): 1559-1563.
28. Smets EM, Garssen B. Cull A, de'Haes JC. Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy. Br J Cancer 1996; 73(2): 241-245.
29. Hagelin CL, Wengström Y, Runesdotter S. Fiirst CJ. The psychometric properties of the Swedish Multidimensional Fatigue Inventory MFI-20 in four different populations. Acta Oncol 2007; 46(1): 97-104.
30. Kuhnt S, Ernst J, Singer S, Riiffer JU, Kortmann RD. Stolzenburg JU, Schwarz R. Fatigue in cancer survivors-prevalence and correlates. Onkoiogie 2009; 32(6): 312-317.
31. Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale NJ: Lawrence Erlbaum Associates; 1988.
32. Norman GR. Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003; 41(5): 582-592.
33. Baughman RP, Culver DA, Judson MA. A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med 2011; 183(5)573-581.
34. Hamoud S, Srour S, Fruchter O. Vlodavsky E. Hayek T. Lytic bone lesion: presenting finding of sarcoidosis. Isr Med Assoc J 2010; 12(1): 59-60.
35. Costabel U. Skeletal muscle weakness, fatigue and sarcoidosis. Thorax 2005; 60(1): 1-2.
36. Spruit MA, Thomeer MJ, Gosselink R, Troosters T, Kasran A, Debrock AJ, et al. Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status. Thorax 2005; 60(1): 32-38.
37. Rajani R, Prasad S, O'Nunain S, Sohal M, Ghuran A. Heart block: a primary manifestation of sarcoidosis. Europace 2010; 12(2): 284-288.
38. Holmes J, Lazarus A. Sarcoidosis: extrathoracic manifestations. Dis Mon 2009; 55(11): 675-692.
39. Vgontzas AN, Bixler EO, Chrousos GP. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 2005; 9(3): 211-224.
40. Resnick HE, Carter EA, Aloia M, Phillips B. Cross-sectional relationship of reported fatigue to obesity, diet, and physical activity: results from the third national health and nutrition examination survey. J Clin Sleep Med 2006; 2(2): 163-169.
41. Zachariae R, Paulsen K, Mehlsen M, Jensen AB, Johansson A, von der Maase H. Chemotherapy-induced nausea, vomiting, and fatigue-the role of individual differences related to sensory perception and autonomic reactivity. Psychother Psychosom 2007; 76(6): 376-384.